Rich Pharmaceuticals, Inc. (OTCBB:RCHA) announced that it has received $25,000 in funding from existing investor GHS Investments, LLC on April 18, 2017. The note carries a coupon of 10% per annum and would mature on January 30, 2018. The transaction is part of securities purchase agreement where company planned to receive $25,000 upon closing and an additional $25,000 each week for three weeks after closing. The note is issued at an original issue discount of 10%, for gross proceeds of $115,000. The note is convertible into common shares at a conversion price equal to 60% of the lowest trading price during the 10-day period prior to conversion. The company will pay expenses of $5,000. The company issued securities pursuant to exemption provided under Regulation D.